Please use this identifier to cite or link to this item:
|Title:||Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC).|
|Authors:||Horsfield, Mark A.|
|Publisher:||Oxford University Press|
|Citation:||Annals of Oncology, 2006, 17(Supplement 9), p.ix219|
|Description:||This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Annals of Oncology following peer review. The definitive publisher-authenticated version [Annals of Oncology, 2006, 17(Supplement 9), abstract PD732] is available online at: http://annonc.oxfordjournals.org/. This is an abstract of a paper presented at the 31st ESMO Congress 29 September - 3 October, 2006: Istanbul, Turkey. The published versions lists additional authors.|
|Appears in Collections:||Conference Papers & Presentations, Dept. of Cardiovascular Sciences|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.